Corbevax, Covovax, Anti-Viral Drug Molnupiravir Approved by Drug Regulator CDSCO
The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.
Central Drug Authority CDSCO has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological E's jab Corbevax and anti-Covid pill Molnupiravir for restricted use in emergency situation.
Drug regulator CDSCO approves vaccines Corbevax, Covovax, anti-viral drug Molnupiravir for restricted emergency use against COVID-19
— Press Trust of India (@PTI_News) December 28, 2021
Health Minister Dr Mansukh Mandaviya Congratulates India:
Congratulations India 🇮🇳
Further strengthening the fight against COVID-19, CDSCO, @MoHFW_INDIA has given 3 approvals in a single day for:
- CORBEVAX vaccine
- COVOVAX vaccine
- Anti-viral drug Molnupiravir
For restricted use in emergency situation. (1/5)
— Dr Mansukh Mandaviya (@mansukhmandviya) December 28, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Dec 28, 2021 11:20 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
